“J.P. Morgan and the meetings around J.P. Morgan are such a fun week for us in the industry typically, but I have to be blunt: This week has been extra busy. I think the Zoom environment, and the virtual environment, has created an efficiency that’s good for everybody, except the folks that have to present the data because we have to present every 30 minutes without bio breaks,” OncoCyte Corp. President and Chief Executive Officer Ronnie Andrews told BioSpace.